Aew Capital Takes $268 Million Stake in Welltower Amid Institutional Shifts

Aew Capital Management Inc. established a major new position in Welltower Inc. during the third quarter, acquiring 1,163,903 shares valued at approximately $267,977,000. According to a regulatory filing, the healthcare real estate investment trust now represents roughly 17.6% of the investment firm's portfolio, making it Aew Capital's single largest holding and representing about 0.16% of the company's total shares.

Other institutional investors also shifted their allocations in the third quarter. Bahl & Gaynor LLC expanded its position by 211.6%, purchasing 214,997 shares to bring its total holding to 316,619 shares worth $72,898,000. Nemes Rush Group LLC increased its stake by 21,902.0% after acquiring 43,804 shares. Conversely, Candriam S.C.A. reduced its Welltower position by 64.8%, offloading 194,561 shares to close the period with 105,485 shares. Institutional investors and hedge funds collectively hold 94.80% of the stock.

Brokerages have updated their outlooks on the trust following its recent performance. Analysts at JPMorgan Chase & Co. raised their price objective from $260.00 to $273.00 with an overweight rating. According to MarketBeat data, consensus price targets have ranged between $259.81 and $263.10 with an overall Moderate Buy consensus rating. Among surveyed analysts, ratings have varied from one Strong Buy, sixteen to seventeen Buys, and three to four Holds.

In its quarterly financial results released on Monday, October 26th, Welltower posted earnings of $1.67 per share, surpassing consensus expectations of $1.64. Quarterly revenue totaled $3.72 billion, topping the projected $3.64 billion and growing 38.4% compared to the prior-year period. The business reported a return on equity of 3.61% and a net margin of 12.08%.

Welltower previously declared a quarterly dividend of $0.85 per share, representing an annualized payout of $3.40 and a yield of 1.4%. The dividend is scheduled for payment on Thursday, November 19th, to shareholders of record as of Tuesday, November 10th. In earlier insider transactions, Director Andrew Gundlach purchased 5,000 shares on Wednesday, August 26th, at an average price of $242.06 per share.